By Dr Nirupama Darshan Verma

Journal articles

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, '265.5: T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1- and Th17-like Treg.', Transplantation, 108, http://dx.doi.org/10.1097/01.tp.0001065100.92615.5f

Verma N; Kawalia P; Al-atiyah R; Tran G; Rakesh P; Carter N; Hodgkinson S; Bruce H, 2024, '265.7: Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra).', Transplantation, 108, http://dx.doi.org/10.1097/01.tp.0001065108.83650.af

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, '321.1: B cell phenotypes in peripheral blood of patients with renal allograft.', Transplantation, 108, http://dx.doi.org/10.1097/01.tp.0001065376.80110.31

Al-atiyah R; Verma N; Kawalia P; Tran G; Hodgkinson S; Hall B, 2024, '361.6: Activation of human CD4+CD25+CD127lo Treg with alloantigen and rIL-2 induces IFNGR.', Transplantation, 108, http://dx.doi.org/10.1097/01.tp.0001065872.18320.b6

Cheung J; Zahorowska B; Suranyi M; Wong JKW; Diep J; Spicer ST; Verma ND; Hodgkinson SJ; Hall BM, 2022, 'CD4+CD25+ T regulatory cells in renal transplantation', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1017683

Tran GT; Verma ND; Smyth LM; Hall BM, 2022, 'Editorial: Characterisation, functions and roles of antigen-specific regulatory T cells in health and disease', Frontiers in Immunology, 13, pp. 1022813, http://dx.doi.org/10.3389/fimmu.2022.1022813

Hall BM; Verma ND; Tran GT; Hodgkinson SJ, 2022, 'Transplant Tolerance, Not Only Clonal Deletion', Frontiers in Immunology, 13, pp. 810798, http://dx.doi.org/10.3389/fimmu.2022.810798

Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ, 2021, 'Multiple sclerosis patients have reduced resting and increased activated CD4⁺CD25⁺FOXP3⁺T regulatory cells', Scientific Reports, 11, pp. 10476, http://dx.doi.org/10.1038/s41598-021-88448-5

Hall BM; Hall RM; Tran GT; Robinson CM; Wilcox PL; Rakesh PK; Wang C; Sharland AF; Verma ND; Hodgkinson SJ, 2021, 'Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4⁺CD25⁺ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor', Frontiers in Immunology, 12, pp. 714838, http://dx.doi.org/10.3389/fimmu.2021.714838

Tran GT; Hodgkinson SJ; Carter N; Verma ND; Robinson CM; Plain KM; Nomura M; Hall BM, 2020, 'Autoantigen specific IL-2 activated CD4⁺CD25⁺T regulatory cells inhibit induction of experimental autoimmune neuritis', Journal of Neuroimmunology, 341, http://dx.doi.org/10.1016/j.jneuroim.2020.577186

Verma ND; Al-Atiyah R; Tran GT; Hodgkinson SJ; Hall BM, 2020, 'CHANGES IN PHENOTYPE OF HUMAN CD4+CD25+CD127LO TREG SUBPOPULATIONS AFTER CULTURE WITH RIL-2 AND ALLOANTIGEN', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699152.96447.5a

Rakesh P; Verma ND; Bedi SK; Tran GT; Robinson CM; Hodgkinson SJ; Hall BM, 2020, 'COMPARISON OF TRITIATED THYMIDINE INCORPORATION ASSAY AND AN IN VITRO SUPPRESSION ASSAY OF CD4+CD25-T EFFECTOR CELL PROLIFERATION BY TH2-LIKE TREG AND NAÏVE TREG USING A FLOW CYTOMETRY BASED ASSAY', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699156.74079.68

Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM, 2019, 'Alloactivation of naïve CD4⁺ CD8⁻ CD25⁺T regulatory cells: Expression of CD8α identifies potent suppressor cells that can promote transplant tolerance induction', Frontiers in Immunology, 10, pp. 2397, http://dx.doi.org/10.3389/fimmu.2019.02397

Singh P; de Souza P; Scott KF; Hall BM; Verma ND; Becker TM; Toh JWT; Sajinovic M; Spring KJ, 2019, 'Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?', Translational Medicine Communications, 4, http://dx.doi.org/10.1186/s41231-019-0032-9

Tran GT; Wilcox PL; Dent LA; Robinson CM; Carter N; Verma ND; Hall BM; Hodgkinson SJ, 2017, 'Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4⁺CD25⁺ T Regulatory Cells', Frontiers in Immunology, 8, pp. 1453, http://dx.doi.org/10.3389/fimmu.2017.01453

Hall BM; Robinson CM; Plain KM; Verma ND; Tran GT; Nomura M; Carter N; Boyd R; Hodgkinson SJ, 2017, 'Changes in reactivity in vitro of CD4⁺ CD25⁺ and CD4⁺ CD25⁻ T Cell subsets in transplant tolerance', Frontiers in Immunology, 8, pp. 994, http://dx.doi.org/10.3389/fimmu.2017.00994

Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ, 2017, 'Cytokines affecting CD4⁺ T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4⁺ T regulatory cells', Transplant Immunology, 43-44, pp. 33 - 41, http://dx.doi.org/10.1016/j.trim.2017.06.003

Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM, 2017, 'Cytokines affecting CD4⁺ T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4⁺ T regulatory cells', Transplant Immunology, 42, pp. 24 - 33, http://dx.doi.org/10.1016/j.trim.2017.05.002

Ju X; Silveira PA; Hsu WH; Elgundi Z; Alingcastre R; Verma ND; Fromm PD; Hsu JL; Bryant C; Li Z; Kupresanin F; Lo TH; Clarke C; Lee K; Mcguire H; Barbara BF; Larsen SR; Gibson J; Bradstock KF; Clark GJ; Hart DNJ, 2016, 'The analysis of CD83 expression on human immune cells identifies a unique CD83⁺-activated T cell population', Journal of Immunology, 197, pp. 4613 - 4625, http://dx.doi.org/10.4049/jimmunol.1600339

Lo TH; Silveira PA; Fromm PD; Verma ND; Vu PA; Kupresanin F; Adam R; Kato M; Cogger VC; Clark GJ; Hart DNJ, 2016, 'Characterization of the expression and function of the C-type lectin receptor CD302 in mice and humans reveals a role in dendritic cell migration', Journal of Immunology, 197, pp. 885 - 898, http://dx.doi.org/10.4049/jimmunol.1600259

Fromm PD; Papadimitrious MS; Hsu JL; Van Kooten Losio N; Verma ND; Lo TH; Silveira PA; Bryant CE; Turtle CJ; Prue RL; Vukovic P; Munster DJ; Nagasaki T; Barnard RT; Mahler SM; Anguille SA; Berneman Z; Horvath LG; Bradstock KF; Joshua DE; Clark GJ; Hart DNJ, 2016, 'CMRF-56⁺ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses', OncoImmunology, 5, http://dx.doi.org/10.1080/2162402X.2016.1168555

Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DNJ, 2016, 'Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation', Leukemia, 30, pp. 692 - 700, http://dx.doi.org/10.1038/leu.2015.231

Hart DNJ; Silveira P; Lo TH; Verma N; Vu A; Kato M; Clark G, 2015, 'Functional Studies on the C-Type Lectin Receptor CD302 Present on Dendritic Cells and Macrophages', Blood, 126, pp. 2198 - 2198, http://dx.doi.org/10.1182/blood.v126.23.2198.2198

Papadimitrious M; Anguille S; Bryant C; Kupresanin F; Verma N; Lo K; Clark G; Newman E; Bradstock K; Berneman Z; Fromm P; Hart D, 2015, 'mRNA loaded CMRF-56+ dendritic cells: a novel anti-cancer vaccination strategy (VAC13P.1122)', The Journal of Immunology, 194, pp. 214.2 - 214.2, http://dx.doi.org/10.4049/jimmunol.194.supp.214.2

Verma ND; Hall BM; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ, 2014, 'Interleukin-12 (IL-12p70) promotes induction of nighty potent Th1-like CD4(+)CD25(+)T regulatory cells that inhibit allograft rejection in unmodified recipients', FRONTIERS IN IMMUNOLOGY, 5, http://dx.doi.org/10.3389/fimmu.2014.00190

Verma ND; Hall BM; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ; Verma N, 2014, 'Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4⁺CD25⁺ T regulatory cells that inhibit allograft rejection in unmodified recipients', Frontiers in Immunology, 5, pp. 190, http://dx.doi.org/10.3389/fimmu.2014.00190

Hall BM; Tran GT; Verma ND; Plain KM; Robinson CM; Nomura M; Hodgkinson SJ, 2013, 'Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity?', Frontiers in Immunology, 4, http://dx.doi.org/10.3389/fimmu.2013.00208

Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM, 2013, 'Cytokines affecting CD4⁺ T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4⁺CD25⁺ Treg', Transplant Immunology, 29, pp. 51 - 59, http://dx.doi.org/10.1016/j.trim.2013.10.003

Hart DNJ; Verma ND; Clark GJ; Fromm PD; Shahin K; Larsen S; Bradstock K, 2013, 'Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy', Biology of Blood and Marrow Transplantation, 19, pp. S311 - S311, http://dx.doi.org/10.1016/j.bbmt.2012.11.460

Russell PJ; Soekmadji C; Thierry B; Cowin G; Strait-Gardner T; Verma N; Xiaochun W; Khatri A, 2012, 'Abstract C30: Use of targeted magnetic nanoparticles for imaging in prostate cancer', Cancer Research, 72, pp. C30 - C30, http://dx.doi.org/10.1158/1538-7445.prca2012-c30

Tran GT; Hodgkinson SJ; Carter N; Verma ND; Plain KM; Boyd RA; Robinson C; Nomura M; Killingsworth MC; Hall BM, 2012, 'IL-5 promotes induction of antigen-specific CD4 +CD25 + T regulatory cells that suppress autoimmunity', Blood, 119, pp. 4441 - 4450, http://dx.doi.org/10.1182/blood-2011-12-396101

Jeet V; Russell PJ; Verma ND; Khatri A, 2012, 'Targeting Aurora Kinases: A novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer', Current Cancer Drug Targets, 12, pp. 144 - 163, http://dx.doi.org/10.2174/156800912799095180

Hall BM; Verma ND; Tran GT; Hodgkinson SJ, 2011, 'Distinct regulatory CD4+T cell subsets; differences between naı ̈ve and antigen specific T regulatory cells', Current Opinion in Immunology, 23, pp. 641 - 647, http://dx.doi.org/10.1016/j.coi.2011.07.012

Singh PP; Joshi SB; Russell PJ; Verma ND; Wang X; Khatri A, 2011, 'Molecular chemotherapy and chemotherapy: A new front against late-stage hormone-refractory prostate cancer', Clinical Cancer Research, 17, pp. 4006 - 4018, http://dx.doi.org/10.1158/1078-0432.CCR-11-0248

Tran GT; Hodgkinson SJ; Carter N; Killingsworth MC; Nomura M; Verma ND; Plain KM; Boyd RA; Hall BM, 2010, 'Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis', Journal of Neuroimmunology, 229, pp. 98 - 106, http://dx.doi.org/10.1016/j.jneuroim.2010.07.010

Verma ND; Plain KM; Nomura M; Tran GT; Boyd RA; Hodgkinson SJ; Hall BM; Robinson C, 2009, 'CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses', Blood, 113, pp. 479 - 487

Verma ND; Plain KM; Nomura M; Tran GT; Boyd R; Carter N; Robinson C; Wang C; Bishop GA; Hodgkinson SJ; Hall BM, 2008, '+CD25+FOXP3+T ALLOANTIGEN ACTIVATED NAIVE CD4 REGULATORY CELLS EXPRESS CD8; A MARKER OF NEWLY ACTIVATED ANTIGEN SPECIFIC T REGULATORY CELLS', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331421.48421.97

Hall B; Plain K; Nomura M; Verma N; Tran G; Boyd R; Robinson C; Hodgkinson S, 2008, 'ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERLEUKIN-5 (IL-5), NOT IL-4.', Transplantation, 86, pp. 136 - 136, http://dx.doi.org/10.1097/01.tp.0000332495.28926.ce

Verma ND; Plain KM; Nomura M; Robinson C; Tran GT; Boyd R; Hodgkinson SJ; Hall BM, 2008, 'ANTIGEN SPECIFIC T REGULATORY CELLS FROM TOLERANT HOSTS EXHIBIT PHENOTYPES SIMILAR TO CELLS THAT WERE ACTIVATED IN VITRO AND USED TO INDUCE TOLERANCE', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331422.56045.85

Plain K; Verma N; Robinson C; Tran G; Boyd R; Hodgkinson S; Hall B, 2008, 'IL-4 HAS TOLEROGENIC AND ALLOGENIC EFFECTS: IT ACTIVATES CD4+CD25+ T CELLS TO INDUCE SPECIFIC TRANSPLANT TOLERANCE AND PROMOTES REJECTION, EFFECTING CD4+CD25-T CELLS TO EXPRESS CD25 BUT NOT FOXP3.', Transplantation, 86, pp. 513 - 514, http://dx.doi.org/10.1097/01.tp.0000331185.87776.58

Hall BM; Robinson C; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ, 2008, 'Studies on naive CD4(+) CD25(+) T cells inhibition of naive CD4(+) CD25(-)T cells in mixed lymphocyte cultures', Transplant Immunology, 18, pp. 291 - 301, http://dx.doi.org/10.1016/j.trim.2007.09.002

Davidson C; Verma ND; Robinson C; Plain KM; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'IL-13 prolongs allograft survival: Association with inhibition of macrophage cytokine activation', Transplant Immunology, 17, pp. 178 - 186

Hall BM; Plain KM; Verma ND; Tran GT; Boyd RA; Robinson C; Nicolls M; Berger M; Nomura M; Hodgkinson SJ, 2007, 'Transfer of allograft specific tolerance requires CD4(+)CD25(+)T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens', Transplantation, 83, pp. 1075 - 1084

Plain KM; Boyd RA; Verma ND; Robinson C; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration', Transplantation, 83, pp. 764 - 773

Verma ND; Boyd RA; Robinson C; Plain KM; Tran GT; Hall BM, 2006, 'IL-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production', Transplantation, 82, pp. 1324 - 1333

Nomura M; Plain KM; Verma ND; Robinson C; Boyd RA; Hodgkinson SJ; Hall BM, 2006, 'The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells / CD4+CD25− T cells determines rejection or tolerance', Transplant Immunology, 15, pp. 311 - 318

C R; J C; Xy H; N V; K P; R B; BM H, 2002, 'ROLE OF CD4⁺CD25⁺ T CELLS IN THE ALLOIMMUNE RESPONSES', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-25.x

Bm H; J C; C R; Xy H; N V; SJ H, 2002, 'THERAPY WITH mAb TO CD25 BLOCKS FUNCTION OF CD4⁺, CD25⁺ T REGULATORY CELLS WHICH MAINTAIN TRANSPLANTATION TOLERANCE', Nephrology, 7, http://dx.doi.org/10.1046/j.1440-1797.2002.00007-1-111.x

He XY; Verma ND; Chen JC; Robinson C; Boyd RA; Hall BM, 2001, 'IL-5 Prolongs Allograft Survival by Downregulating IL-2 and IFN-y Cytokines', Transplantation Proceedings, pp. 703 - 704

He XY; Verma ND; Plain KM; Hall BM, 1999, 'Cloning and expression of interleukin 5 from the rat', Transplantation Proceedings, pp. 1574 - 1576

Back to profile page